Common use of OTHER MATTER Clause in Contracts

OTHER MATTER. The consolidated statement of financial position of Vibhavadi Medical Center Public Company Limited and its subsidiaries and the separate statement of financial position of Vibhavadi Medical Center Public Company Limited as at December 31, 2021, presented as comparative information, were audited by another auditor in the same office, who issued his audit report dated February 25, 2022 expressed an unqualified opinion. The consolidated statement of comprehensive of income, the consolidated statement of changes in shareholders’ equity and the consolidated statement of cash flows of Vibhavadi Medical Center Public Company Limited and its subsidiaries and the separate statement of comprehensive income, the separate statement of changes in shareholders’ equity and the separate statement cash flows of Vibhavadi Medical Center Public Company Limited for the three-month and nine-month periods ended September 30, 2021, presented as comparative information, were reviewed by another auditor in the same office, who issued his audit report dated November 15, 2021 expressed an unqualified conclusion. Based on my review, nothing has come to my attention that causes me to believe that the accompanying interim financial information is not prepared, in all material respects, in accordance with Thai Accounting Standard No. 34 “Interim Financial Reporting”. Dharmniti Auditing Company Limited Bangkok, Thailand November 14, 2022 "UNAUDITED" "REVIEWED" - 3 - AS AT SEPTEMBER 30, 2022 ASSETS Baht Consolidated financial statements Separate financial statements As at September As at December As at September As at December Notes 30, 2022 31, 2021 30, 2022 31, 2021 Current assets Cash and cash equivalents 5 470,150,421 511,786,013 129,774,682 70,760,749 Trade receivables 4, 6 400,843,389 356,355,779 173,231,630 146,929,519 Accrued revenues from hospital operations 6 801,741,968 624,730,647 128,015,237 126,332,201 Advance payment for vaccine alternative Covid-19 4 2,875,000 217,866,050 - 156,806,600 Accrued dividend income 4 1,800,000 1,800,000 - - Short-term loans to related parties 4, 7 223,300,000 262,300,000 223,300,000 262,300,000 Current portion of long-term loans to other persons 1,765,000 1,680,000 - - Inventories 8 194,435,521 182,440,750 55,836,094 61,816,292 Other current financial assets 4, 10 1,027,601,000 757,619,998 1,027,601,000 757,619,998 Other current assets 4 45,936,951 49,147,951 15,140,676 17,302,331 Total current assets 3,170,449,250 2,965,727,188 1,752,899,319 1,599,867,690 Non-current assets Fixed deposits pledged as collateral 9 39,927,925 50,575,874 - - Other non-current financial assets 4, 10 15,282,224,778 12,290,973,926 10,246,971,594 8,516,663,784 Investments in associates 11 3,199,195,914 2,996,605,672 1,703,494,168 1,703,494,168 Investments in subsidiaries 12 - - 1,656,112,409 1,716,071,896 Long-term loans to related parties 4 24,000,000 24,000,000 - - Long-term loans to other persons 38,716,857 29,771,857 - - Investment property 13 436,209,846 434,528,456 362,654,416 359,335,232 Property, plant and equipment 14 8,395,954,396 8,558,632,798 1,098,763,837 1,126,708,244 Right-of-use assets 15 26,551,026 264,051,602 13,428,879 16,206,273 Goodwill 723,215,731 723,215,731 - - Intangible assets 13,264,824 15,153,918 663,298 772,023 Deferred tax assets 16 12,565,086 11,044,791 - - Advance payment for assets 4,135,794 51,615,987 - 47,204,850 Other non-current assets 12,868,530 10,770,664 2,151,123 2,766,616 Total non-current assets 28,208,830,707 25,460,941,276 15,084,239,724 13,489,223,086 TOTAL ASSETS 31,379,279,957 28,426,668,464 16,837,139,043 15,089,090,776 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" - 4 - LIABILITIES AND SHAREHOLDERS' EQUITY Baht Consolidated financial statements Separate financial statements As at September As at December As at September As at December Notes 30, 2022 31, 2021 30, 2022 31, 2021 Current liabilities Bank overdarfts and short-term loans from financial institutions 17 4,506,347,747 3,821,506,379 3,280,000,000 2,740,000,000 Trade payables 4 419,141,232 398,333,646 116,142,678 112,223,155 Advance received from alternative vaccine Covid-19 400,678 324,141,324 - 293,670,056 Accrued doctor fee 237,341,253 216,828,881 98,899,051 93,823,407 Accrued expenses 4 124,574,869 168,529,241 29,969,025 105,411,652 Accrued dividends 27,699,857 24,580,167 17,267,271 15,222,804 Payable from acquisition of assets 4 119,349,128 154,436,309 1,188,718 4,842,073 Current portion of long-term liabilities Long-term loans from financial institution 20 1,340,080,006 1,345,080,005 713,525,720 719,525,720 Lease liabilities 21 7,632,819 22,591,526 4,457,371 6,315,949 Short-term loans from related parties 4, 18 267,300,000 268,800,000 - - Short-term loans from other persons and other company 19 120,227,420 81,300,000 25,927,420 - Income tax payable 106,505,929 127,380,221 58,809,644 90,524,391 Advance received from social security office 26 350,944,553 370,144,553 - - Other current liabilities 4 88,240,687 50,729,673 16,490,595 47,214,973 Total current liabilities 7,715,786,178 7,374,381,925 4,362,677,493 4,228,774,180 Non-current liabilities Long-term loans from financial institutions 20 2,933,515,497 3,551,525,502 942,959,500 1,262,103,790 Lease liabilities 21 23,104,340 267,126,327 10,520,644 13,849,713 Long-term loans from related parties 4, 18 202,000,000 155,000,000 227,000,000 155,000,000 Deferred tax liabilities 16 1,995,679,464 1,482,606,553 1,011,850,925 735,715,039 Provisions for employee benefit 22 287,334,225 272,263,545 85,172,881 91,259,325 Other non-current liabilities 4 40,643,780 67,187,975 14,391,032 15,313,158 Total non-current liabilities 5,482,277,306 5,795,709,902 2,291,894,982 2,273,241,025 TOTAL LIABILITIES 13,198,063,484 13,170,091,827 6,654,572,475 6,502,015,205 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" Baht Consolidated financial statements Separate financial statements As at September As at December As at September As at December Notes 30, 2022 31, 2021 30, 2022 31, 2021 Shareholders' equity Share capital 23 Authorized share capital 16,019,683,830 ordinary shares, Baht 0.10 each 1,601,968,383 1,601,968,383 14,939,082,816 ordinary shares, Baht 0.10 each 1,493,908,282 1,493,908,282 Issued and paid-up share capital 13,576,011,474 ordinary shares, Baht 0.10 each 1,357,601,147 1,357,601,147 13,575,865,582 ordinary shares, Baht 0.10 each 1,357,586,558 1,357,586,558 Premium on share capital 2,718,559,728 2,718,137,663 2,718,559,728 2,718,137,663 Retained earnings Appropriated Legal reserve 149,390,828 149,390,828 149,390,828 149,390,828 Unappropriated 4,271,811,378 3,729,084,936 1,706,269,862 1,355,614,395 Other components of shareholders' equity 10.1, 11.3 5,949,777,953 4,230,064,717 4,250,745,003 3,006,346,127 Total equity attributable to owners of the parent 14,447,141,034 12,184,264,702 10,182,566,568 8,587,075,571 Non-controlling interests 3,734,075,439 3,072,311,935 - - TOTAL SHAREHOLDERS' EQUITY 18,181,216,473 15,256,576,637 10,182,566,568 8,587,075,571 TOTAL LIABIBITIE AND SHAREHOLDERS' EQUITY 31,379,279,957 28,426,668,464 16,837,139,043 15,089,090,776 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" - 6 - FOR THE THREE-MONTH PERIOD ENDED SEPTEMBER 30, 2022 Baht Consolidated financial statements Separate financial statements Notes 2022 2021 2022 2021 Revenues Revenues from medical treatment 4 2,155,163,346 1,895,010,776 814,506,560 844,090,017 Rental and service income 4 18,081,940 15,832,052 18,830,484 16,299,479 Gain (loss) on sale of investments in equity (43,471,819) 1,914,030 (43,471,819) 1,914,030 Dividend income 4, 10, 11, 12 87,813,447 50,311,033 67,104,150 39,367,683 Gain (loss) on sale of investments in subsidiary 12 (14,866,224) - 4,163,495 - Other income 4 27,554,391 19,153,239 14,397,821 10,454,296 Total revenues 2,230,275,081 1,982,221,130 875,530,691 912,125,505 Expenses Cost of medical treatment 4 1,422,953,034 1,248,129,753 432,248,549 510,148,581 Cost of rental and service 4 10,760,812 11,636,636 10,760,811 8,794,829 Administrative and services expenses 4 264,504,868 232,499,406 98,125,978 98,465,395 Loss on fair value measurement of financial assets 34,670,975 87,599,842 34,670,975 87,599,842 Total expenses 1,732,889,689 1,579,865,637 575,806,313 705,008,647 Profit from operating activities 497,385,392 402,355,493 299,724,378 207,116,858 Finance costs 4 61,601,273 52,670,324 31,932,254 30,472,313 Share of profit of associates 11.2 62,937,196 407,626,526 - - Profit before income tax expenses 498,721,315 757,311,695 267,792,124 176,644,545 Income tax expenses 27 98,091,208 50,517,131 58,511,423 27,517,628 Profit for the period from continuing operations 400,630,107 706,794,564 209,280,701 149,126,917 Discontinued operation Loss for the period from discontinued operations 28 (12,953,267) (19,580,348) - - Profit for the period 387,676,840 687,214,216 209,280,701 149,126,917 Other comprehensive income Item that will not be reclassified subsequently to profit or loss Gain on investments in equity designated at fair value through other comprehensive income 1,135,099,331 973,267,888 810,731,642 772,133,964 Share of other comprehensive gain of associates 11.3 (17,731,778) (3,205,147) - - Income tax relating to items that will not be reclassified subsequently to profit or loss 27 (207,996,606) (193,920,411) (143,271,208) (153,693,625) Other comprehensive income for the period, net of income tax 909,370,947 776,142,330 667,460,434 618,440,339 Total comprehensive income for the period 1,297,047,787 1,463,356,546 876,741,135 767,567,256 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" from continuing operations from discontinued operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations Baht Consolidated financial statements Separate financial statements 2022 2021 2022 2021 (19,580,348) 387,676,840 687,214,216 209,280,701 149,126,917 1,297,047,787 1,463,356,546 876,741,135 767,567,256 Earnings per share 30 Basic earnings per share Attributable to owners of the parent from continuing operations 0.0243 0.0494 0.0154 0.0110 from discontinued operations (0.0010) (0.0015) - - Attributable to owners of the parent from continuing operations from discontinued operations 0.0243 0.0450 0.0154 0.0100 (0.0010) (0.0013) - - 0.0233 0.0437 0.0154 0.0100 0.0233 0.0479 0.0154 0.0110 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" - 8 - FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2022 Baht Consolidated financial statements Separate financial statements Notes 2022 2021 2022 2021 Revenues Revenues from medical treatment 4 6,666,763,946 4,951,934,066 2,454,948,755 2,016,859,325 Rental and service income 4 53,671,650 44,906,451 58,478,821 47,784,859 Gain (loss) on sale of investments in equity (20,858,407) 20,900,205 (20,858,407) 20,900,205 Dividend income 4, 10, 11, 12 273,071,811 166,002,212 595,102,924 295,083,854 Gain (loss) on sale of investments in subsidiary 12 (14,866,224) - 4,163,495 - Other income 4 81,651,974 65,329,683 35,808,046 34,419,361 Total revenues 7,039,434,750 5,249,072,617 3,127,643,634 2,415,047,604 Expenses Cost of medical treatment 4 4,391,862,627 3,498,789,024 1,492,819,355 1,314,170,861 Cost of rental and service 4 27,881,107 29,103,123 30,263,832 26,505,673 Administrative and services expenses 4 792,392,567 684,596,693 296,988,809 287,323,659 (Gain) loss on fair value measurement of financial assets 182,897,083 (19,337,808) 182,897,083 (19,337,808) Total expenses 5,395,033,384 4,193,151,032 2,002,969,079 1,608,662,385 Profit from operating activities 1,644,401,366 1,055,921,585 1,124,674,555 806,385,219 Finance costs 4 180,094,610 146,171,279 92,906,307 88,734,845 Share of profit of associates 11.2 164,768,713 463,571,203 - - Profit before income tax expenses 1,629,075,469 1,373,321,509 1,031,768,248 717,650,374 Income tax expenses 27 255,227,401 140,891,055 104,414,869 83,146,186 Profit for the period from continuing operations 1,373,848,068 1,232,430,454 927,353,379 634,504,188 Discontinued operation Loss for the period from discontinued operations 28 (35,889,623) (27,040,624) - - Profit for the period 1,337,958,445 1,205,389,830 927,353,379 634,504,188 Other comprehensive income Item that will not be reclassified subsequently to profit or loss Gain on investments in equity designated at fair value through other comprehensive income 2,900,894,957 1,905,830,248 1,649,873,603 1,744,258,730 Actuarial gain on defined employee benefit plans 22 9,650,094 - 9,650,094 - Share of other comprehensive gain of associates 11.3 4,804,650 43,055,876 - - Income tax relating to items that will not be reclassified subsequently to profit or loss 27 (562,590,885) (380,432,883) (313,029,619) (348,118,578) Other comprehensive income for the period, net of income tax 2,352,758,816 1,568,453,241 1,346,494,078 1,396,140,152 Total comprehensive income for the period 3,690,717,261 2,773,843,071 2,273,847,457 2,030,644,340 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" Baht Separate financial statements from continuing operations from discontinued operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations 2022 2021 2022 2021 3,726,606,884 2,800,883,695 2,273,847,457 2,030,644,340 1,337,958,445 1,205,389,830 927,353,379 634,504,188 3,690,717,261 2,773,843,071 2,273,847,457 2,030,644,340 Earnings per share 30 Basic earnings per share Attributable to owners of the parent from continuing operations 0.0843 0.0840 0.0683 0.0467 from discontinued operations (0.0026) (0.0019) - - Attributable to owners of the parent from continuing operations from discontinued operations 0.0843 0.0766 0.0683 0.0426 (0.0026) (0.0018) - - 0.0817 0.0748 0.0683 0.0426 0.0817 0.0821 0.0683 0.0467 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2022 Baht Consolidated financial statements Equity attributable to owners of the parent Non-controlling Total Issued and Share premium Retained earnings Other components of shareholders' equity Total equity interests Shareholders' paid-up share account Appropriated Unappropriated Unrealized gain Unrealized gain Unrealized loss Difference from Total other attributable to equity capital Legal reserve (loss) on (loss) on on investment change in shareholding components owners of investments investment in associates proportion in subsidiary shareholders' the parent in equity in associates equity 1,357,586,558 2,718,137,663 149,390,828 3,729,084,936 3,983,057,900 232,007,542 (592,389) 15,591,664 4,230,064,717 12,184,264,702 3,072,311,935 15,256,576,637 Notes Balance as at January 1, 2022 Paid-up share capital 24 Dividend paid 25 Non-contralling interest increase from acquisition of investment in subsidiaries - - - - - - - - - - 2,000,000 2,000,000 Total comprehensive income for the period Profit for the period - - - 1,108,728,625 - - - - - 1,108,728,625 229,229,820 1,337,958,445 Other comprehensive income for the period, net of income tax Gain on valuation of investments - - - - 1,810,433,012 - - - 1,810,433,012 1,810,433,012 529,801,079 2,340,234,091 Gain on derecognition of investment in equity designated at fair value through other comprehersive income - 95,524,426 Actuarial gain on defined employee benefit plans - 7,720,075 - - Share of other comprehensive gain of associates - - 4,804,650 - Balance as at September 30, 2022 2,718,559,728 4,271,811,378 236,812,192 15,591,664 149,390,828 3,734,075,439 Notes to the interim financial statements form an integral part of these financial statements. "UNAUDITED" "REVIEWED" FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2022

OTHER MATTER. The consolidated statement statements of financial position of Vibhavadi Medical Center Green Resources Public Company Limited and its subsidiaries subsidiaries, and the separate statement statements of financial position of Vibhavadi Medical Center Green Resources Public Company Limited as at December 31, 20212019 , presented as herewith for comparative information, were audited by another auditor who expressed an unqualified opinion in the same office, who issued his audit report dated February 2526, 2022 expressed an unqualified opinion. The consolidated statement of comprehensive of income2020, the consolidated statement of changes in shareholders’ equity and the consolidated statement of cash flows of Vibhavadi Medical Center Public Company Limited and its subsidiaries and the separate statement statements of comprehensive income, the separate statement of changes in shareholders’ equity and the separate statement cash flows of Vibhavadi Medical Center Public Company Limited income for the three-month and nine-month periods ended September 30, 20212019 , changes in shareholders’ equity and consolidated cash flows for the nine-month period ended September 30, 2019 of Green Resources Public Company Limited and its subsidiaries, and the separate statements of comprehensive income for the three-month and nine-month periods ended September 30, 2019 , changes in shareholders’ equity and cash flows for the nine-month period ended September 30, 2019 of Green Resources Public Company Limited, presented as herewith for comparative information, were reviewed by another auditor in the same office, who issued his audit report dated November 15, 2021 expressed an unqualified conclusion. Based on my review, stated that nothing has had come to my his attention that causes me caused him to believe that the accompanying interim financial information is was not prepared, in all material respects, in accordance with Thai Accounting Standard No. 34 No.34 “Interim Financial Reporting”” in his report dated November 8, 2019. Dharmniti Auditing Company Limited Bangkok, Thailand November 1411, 2022 2020 "UNAUDITED" "REVIEWED" - 3 - AS AT SEPTEMBER 30, 2022 ASSETS UNAUDITED"‌ Thousand Baht Consolidated financial statements Separate financial statements As at September As at December As at September As at December Notes Note 30, 2022 2020 31, 2021 2019 30, 2022 2020 31, 2021 2019 Current assets Cash and cash equivalents 5 470,150,421 511,786,013 129,774,682 70,760,749 10,552 9,299 5,361 3,608 Trade and other current receivables 4, 5.4, 6 400,843,389 356,355,779 173,231,630 146,929,519 Accrued revenues from hospital operations 6 801,741,968 624,730,647 128,015,237 126,332,201 Advance payment for vaccine alternative Covid-19 4 2,875,000 217,866,050 - 156,806,600 Accrued dividend income 4 1,800,000 1,800,000 - - 60,516 61,940 19,761 14,929 Short-term loans to loan related parties 4, 7 223,300,000 262,300,000 223,300,000 262,300,000 Current portion of long-term loans to other persons 1,765,000 1,680,000 company 5.4 30,000 - 30,000 - Inventories 7 6,708 - 6,320 - Costs of property development projects 8 194,435,521 182,440,750 55,836,094 61,816,292 98,197 102,589 21,243 23,027 Current tax assets 190 425 180 368 Other current financial assets 4, 10 1,027,601,000 757,619,998 1,027,601,000 757,619,998 Other current assets 4 45,936,951 49,147,951 15,140,676 17,302,331 9 8,100 - 8,100 - Total current assets 3,170,449,250 2,965,727,188 1,752,899,319 1,599,867,690 214,263 174,253 90,965 41,932 Non-current assets Fixed deposits pledged as collateral 9 39,927,925 50,575,874 - - Other non-current financial assets asset 4, 10 15,282,224,778 12,290,973,926 10,246,971,594 8,516,663,784 Investments in associates 11 3,199,195,914 2,996,605,672 1,703,494,168 1,703,494,168 Investments 46,939 - 46,939 - Bank deposits pledged as collateral 9,888 8,041 - - Investment in subsidiaries 12 10 - - 1,656,112,409 1,716,071,896 256,857 164,162 Other long-term investments 4, 11 - 46,939 - 46,939 Long-term loans to related parties 4 24,000,000 24,000,000 - - companies 5.4 51,000 89,250 175,137 294,400 Long-term loans to other persons 38,716,857 29,771,857 companies 12 3,512 4,602 - - Investment property 13 436,209,846 434,528,456 362,654,416 359,335,232 118,315 121,840 118,315 121,840 Property, plant and equipment 14 8,395,954,396 8,558,632,798 1,098,763,837 1,126,708,244 576,152 599,340 75,722 80,115 Right-of-use assets 15 26,551,026 264,051,602 13,428,879 16,206,273 Goodwill 723,215,731 723,215,731 50,651 - 560 - Intangible assets 13,264,824 15,153,918 663,298 772,023 16 33,441 34,480 28 16 Deferred tax assets 16 12,565,086 11,044,791 122 122 - - Advance payment for assets 4,135,794 51,615,987 - 47,204,850 Other non-current assets 12,868,530 10,770,664 2,151,123 2,766,616 50 831 14 13 Total non-current assets 28,208,830,707 25,460,941,276 15,084,239,724 13,489,223,086 TOTAL ASSETS 31,379,279,957 28,426,668,464 16,837,139,043 15,089,090,776 890,070 905,445 673,572 707,485 Total assets 1,104,333 1,079,698 764,537 749,417 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" - 4 - LIABILITIES AND SHAREHOLDERS' EQUITY Baht Consolidated financial statements Separate financial statements As at September As at December As at September As at December Notes 30, 2022 31, 2021 30, 2022 31, 2021 Current liabilities Bank overdarfts and short-term loans from financial institutions 17 4,506,347,747 3,821,506,379 3,280,000,000 2,740,000,000 Trade payables 4 419,141,232 398,333,646 116,142,678 112,223,155 Advance received from alternative vaccine Covid-19 400,678 324,141,324 - 293,670,056 Accrued doctor fee 237,341,253 216,828,881 98,899,051 93,823,407 Accrued expenses 4 124,574,869 168,529,241 29,969,025 105,411,652 Accrued dividends 27,699,857 24,580,167 17,267,271 15,222,804 Payable from acquisition of assets 4 119,349,128 154,436,309 1,188,718 4,842,073 Current portion of long-term liabilities Long-term loans from financial institution 20 1,340,080,006 1,345,080,005 713,525,720 719,525,720 Lease liabilities 21 7,632,819 22,591,526 4,457,371 6,315,949 Short-term loans from related parties 4, 18 267,300,000 268,800,000 - - Short-term loans from other persons and other company 19 120,227,420 81,300,000 25,927,420 - Income tax payable 106,505,929 127,380,221 58,809,644 90,524,391 Advance received from social security office 26 350,944,553 370,144,553 - - Other current liabilities 4 88,240,687 50,729,673 16,490,595 47,214,973 Total current liabilities 7,715,786,178 7,374,381,925 4,362,677,493 4,228,774,180 Non-current liabilities Long-term loans from financial institutions 20 2,933,515,497 3,551,525,502 942,959,500 1,262,103,790 Lease liabilities 21 23,104,340 267,126,327 10,520,644 13,849,713 Long-term loans from related parties 4, 18 202,000,000 155,000,000 227,000,000 155,000,000 Deferred tax liabilities 16 1,995,679,464 1,482,606,553 1,011,850,925 735,715,039 Provisions for employee benefit 22 287,334,225 272,263,545 85,172,881 91,259,325 Other non-current liabilities 4 40,643,780 67,187,975 14,391,032 15,313,158 Total non-current liabilities 5,482,277,306 5,795,709,902 2,291,894,982 2,273,241,025 TOTAL LIABILITIES 13,198,063,484 13,170,091,827 6,654,572,475 6,502,015,205 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" Baht Consolidated financial statements Separate financial statements As at September As at December As at September As at December Notes 30, 2022 31, 2021 30, 2022 31, 2021 Shareholders' equity Share capital 23 Authorized share capital 16,019,683,830 ordinary shares, Baht 0.10 each 1,601,968,383 1,601,968,383 14,939,082,816 ordinary shares, Baht 0.10 each 1,493,908,282 1,493,908,282 Issued and paid-up share capital 13,576,011,474 ordinary shares, Baht 0.10 each 1,357,601,147 1,357,601,147 13,575,865,582 ordinary shares, Baht 0.10 each 1,357,586,558 1,357,586,558 Premium on share capital 2,718,559,728 2,718,137,663 2,718,559,728 2,718,137,663 Retained earnings Appropriated Legal reserve 149,390,828 149,390,828 149,390,828 149,390,828 Unappropriated 4,271,811,378 3,729,084,936 1,706,269,862 1,355,614,395 Other components of shareholders' equity 10.1, 11.3 5,949,777,953 4,230,064,717 4,250,745,003 3,006,346,127 Total equity attributable to owners of the parent 14,447,141,034 12,184,264,702 10,182,566,568 8,587,075,571 Non-controlling interests 3,734,075,439 3,072,311,935 - - TOTAL SHAREHOLDERS' EQUITY 18,181,216,473 15,256,576,637 10,182,566,568 8,587,075,571 TOTAL LIABIBITIE AND SHAREHOLDERS' EQUITY 31,379,279,957 28,426,668,464 16,837,139,043 15,089,090,776 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" - 6 - FOR THE THREE-MONTH PERIOD ENDED SEPTEMBER 30, 2022 Baht Consolidated financial statements Separate financial statements Notes 2022 2021 2022 2021 Revenues Revenues from medical treatment 4 2,155,163,346 1,895,010,776 814,506,560 844,090,017 Rental and service income 4 18,081,940 15,832,052 18,830,484 16,299,479 Gain (loss) on sale of investments in equity (43,471,819) 1,914,030 (43,471,819) 1,914,030 Dividend income 4, 10, 11, 12 87,813,447 50,311,033 67,104,150 39,367,683 Gain (loss) on sale of investments in subsidiary 12 (14,866,224) - 4,163,495 - Other income 4 27,554,391 19,153,239 14,397,821 10,454,296 Total revenues 2,230,275,081 1,982,221,130 875,530,691 912,125,505 Expenses Cost of medical treatment 4 1,422,953,034 1,248,129,753 432,248,549 510,148,581 Cost of rental and service 4 10,760,812 11,636,636 10,760,811 8,794,829 Administrative and services expenses 4 264,504,868 232,499,406 98,125,978 98,465,395 Loss on fair value measurement of financial assets 34,670,975 87,599,842 34,670,975 87,599,842 Total expenses 1,732,889,689 1,579,865,637 575,806,313 705,008,647 Profit from operating activities 497,385,392 402,355,493 299,724,378 207,116,858 Finance costs 4 61,601,273 52,670,324 31,932,254 30,472,313 Share of profit of associates 11.2 62,937,196 407,626,526 - - Profit before income tax expenses 498,721,315 757,311,695 267,792,124 176,644,545 Income tax expenses 27 98,091,208 50,517,131 58,511,423 27,517,628 Profit for the period from continuing operations 400,630,107 706,794,564 209,280,701 149,126,917 Discontinued operation Loss for the period from discontinued operations 28 (12,953,267) (19,580,348) - - Profit for the period 387,676,840 687,214,216 209,280,701 149,126,917 Other comprehensive income Item that will not be reclassified subsequently to profit or loss Gain on investments in equity designated at fair value through other comprehensive income 1,135,099,331 973,267,888 810,731,642 772,133,964 Share of other comprehensive gain of associates 11.3 (17,731,778) (3,205,147) - - Income tax relating to items that will not be reclassified subsequently to profit or loss 27 (207,996,606) (193,920,411) (143,271,208) (153,693,625) Other comprehensive income for the period, net of income tax 909,370,947 776,142,330 667,460,434 618,440,339 Total comprehensive income for the period 1,297,047,787 1,463,356,546 876,741,135 767,567,256 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" from continuing operations from discontinued operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations Baht Consolidated financial statements Separate financial statements 2022 2021 2022 2021 (19,580,348) 387,676,840 687,214,216 209,280,701 149,126,917 1,297,047,787 1,463,356,546 876,741,135 767,567,256 Earnings per share 30 Basic earnings per share Attributable to owners of the parent from continuing operations 0.0243 0.0494 0.0154 0.0110 from discontinued operations (0.0010) (0.0015) - - Attributable to owners of the parent from continuing operations from discontinued operations 0.0243 0.0450 0.0154 0.0100 (0.0010) (0.0013) - - 0.0233 0.0437 0.0154 0.0100 0.0233 0.0479 0.0154 0.0110 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" - 8 - FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2022 Baht Consolidated financial statements Separate financial statements Notes 2022 2021 2022 2021 Revenues Revenues from medical treatment 4 6,666,763,946 4,951,934,066 2,454,948,755 2,016,859,325 Rental and service income 4 53,671,650 44,906,451 58,478,821 47,784,859 Gain (loss) on sale of investments in equity (20,858,407) 20,900,205 (20,858,407) 20,900,205 Dividend income 4, 10, 11, 12 273,071,811 166,002,212 595,102,924 295,083,854 Gain (loss) on sale of investments in subsidiary 12 (14,866,224) - 4,163,495 - Other income 4 81,651,974 65,329,683 35,808,046 34,419,361 Total revenues 7,039,434,750 5,249,072,617 3,127,643,634 2,415,047,604 Expenses Cost of medical treatment 4 4,391,862,627 3,498,789,024 1,492,819,355 1,314,170,861 Cost of rental and service 4 27,881,107 29,103,123 30,263,832 26,505,673 Administrative and services expenses 4 792,392,567 684,596,693 296,988,809 287,323,659 (Gain) loss on fair value measurement of financial assets 182,897,083 (19,337,808) 182,897,083 (19,337,808) Total expenses 5,395,033,384 4,193,151,032 2,002,969,079 1,608,662,385 Profit from operating activities 1,644,401,366 1,055,921,585 1,124,674,555 806,385,219 Finance costs 4 180,094,610 146,171,279 92,906,307 88,734,845 Share of profit of associates 11.2 164,768,713 463,571,203 - - Profit before income tax expenses 1,629,075,469 1,373,321,509 1,031,768,248 717,650,374 Income tax expenses 27 255,227,401 140,891,055 104,414,869 83,146,186 Profit for the period from continuing operations 1,373,848,068 1,232,430,454 927,353,379 634,504,188 Discontinued operation Loss for the period from discontinued operations 28 (35,889,623) (27,040,624) - - Profit for the period 1,337,958,445 1,205,389,830 927,353,379 634,504,188 Other comprehensive income Item that will not be reclassified subsequently to profit or loss Gain on investments in equity designated at fair value through other comprehensive income 2,900,894,957 1,905,830,248 1,649,873,603 1,744,258,730 Actuarial gain on defined employee benefit plans 22 9,650,094 - 9,650,094 - Share of other comprehensive gain of associates 11.3 4,804,650 43,055,876 - - Income tax relating to items that will not be reclassified subsequently to profit or loss 27 (562,590,885) (380,432,883) (313,029,619) (348,118,578) Other comprehensive income for the period, net of income tax 2,352,758,816 1,568,453,241 1,346,494,078 1,396,140,152 Total comprehensive income for the period 3,690,717,261 2,773,843,071 2,273,847,457 2,030,644,340 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" Baht Separate financial statements from continuing operations from discontinued operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations 2022 2021 2022 2021 3,726,606,884 2,800,883,695 2,273,847,457 2,030,644,340 1,337,958,445 1,205,389,830 927,353,379 634,504,188 3,690,717,261 2,773,843,071 2,273,847,457 2,030,644,340 Earnings per share 30 Basic earnings per share Attributable to owners of the parent from continuing operations 0.0843 0.0840 0.0683 0.0467 from discontinued operations (0.0026) (0.0019) - - Attributable to owners of the parent from continuing operations from discontinued operations 0.0843 0.0766 0.0683 0.0426 (0.0026) (0.0018) - - 0.0817 0.0748 0.0683 0.0426 0.0817 0.0821 0.0683 0.0467 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2022 Baht Consolidated financial statements Equity attributable to owners of the parent Non-controlling Total Issued and Share premium Retained earnings Other components of shareholders' equity Total equity interests Shareholders' paid-up share account Appropriated Unappropriated Unrealized gain Unrealized gain Unrealized loss Difference from Total other attributable to equity capital Legal reserve (loss) on (loss) on on investment change in shareholding components owners of investments investment in associates proportion in subsidiary shareholders' the parent in equity in associates equity 1,357,586,558 2,718,137,663 149,390,828 3,729,084,936 3,983,057,900 232,007,542 (592,389) 15,591,664 4,230,064,717 12,184,264,702 3,072,311,935 15,256,576,637 Notes Balance as at January 1, 2022 Paid-up share capital 24 Dividend paid 25 Non-contralling interest increase from acquisition of investment in subsidiaries - - - - - - - - - - 2,000,000 2,000,000 Total comprehensive income for the period Profit for the period - - - 1,108,728,625 - - - - - 1,108,728,625 229,229,820 1,337,958,445 Other comprehensive income for the period, net of income tax Gain on valuation of investments - - - - 1,810,433,012 - - - 1,810,433,012 1,810,433,012 529,801,079 2,340,234,091 Gain on derecognition of investment in equity designated at fair value through other comprehersive income - 95,524,426 Actuarial gain on defined employee benefit plans - 7,720,075 - - Share of other comprehensive gain of associates - - 4,804,650 - Balance as at September 30, 2022 2,718,559,728 4,271,811,378 236,812,192 15,591,664 149,390,828 3,734,075,439 Notes to the interim financial statements form an integral part of these financial statements. "UNAUDITED" "REVIEWED" FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2022.

OTHER MATTER. The consolidated statement statements of financial position of Vibhavadi Medical Center Green Resources Public Company Limited and its subsidiaries subsidiaries, and the separate statement statements of financial position of Vibhavadi Medical Center Green Resources Public Company Limited as at December 31, 20212019, presented as herewith for comparative information, were audited by another auditor who expressed an unqualified opinion in the same office, who issued his audit report dated February 2526, 2022 expressed an unqualified opinion. The consolidated statement of comprehensive of income2020, the consolidated statement statements of comprehensive income for the three-month and six-month periods ended June 30, 2019, changes in shareholders’ equity and the consolidated statement of cash flows for the six-month period ended June 30, 2019 of Vibhavadi Medical Center Green Resources Public Company Limited and its subsidiaries subsidiaries, and the separate statement statements of comprehensive incomeincome for the three-month and six-month periods ended June 30, the separate statement of 2019, changes in shareholders’ equity and the separate statement cash flows for the six-month period ended June 30, 2019 of Vibhavadi Medical Center Green Resources Public Company Limited for the three-month and nine-month periods ended September 30, 2021Limited, presented as herewith for comparative information, were reviewed by another auditor in the same office, who issued his audit report dated November 15, 2021 expressed an unqualified conclusion. Based on my review, stated that nothing has had come to my his attention that causes me caused him to believe that the accompanying interim financial information is was not prepared, in all material respects, in accordance with Thai Accounting Standard No. 34 No.34 “Interim Financial Reporting”” in his report dated August 9, 2019. Dharmniti Auditing Company Limited Bangkok, Thailand November 14Augest 11, 2022 2020 "UNAUDITED" "REVIEWED" - 3 - AS AT SEPTEMBER 30, 2022 ASSETS UNAUDITED"‌ Thousand Baht Consolidated financial statements Separate financial statements As at September June As at December As at September June As at December Notes Note 30, 2022 2020 31, 2021 2019 30, 2022 2020 31, 2021 2019 Current assets Cash and cash equivalents 5 470,150,421 511,786,013 129,774,682 70,760,749 5,686 9,299 2,436 3,608 Trade and other current receivables 4Related companies 5.4, 6 400,843,389 356,355,779 173,231,630 146,929,519 Accrued revenues from hospital operations 8,545 9,215 11,194 8,287 Other companies 6 801,741,968 624,730,647 128,015,237 126,332,201 Advance payment for vaccine alternative Covid-19 4 2,875,000 217,866,050 - 156,806,600 Accrued dividend income 4 1,800,000 1,800,000 - - 47,952 52,725 4,225 6,642 Short-term loans to loan related parties 4, 7 223,300,000 262,300,000 223,300,000 262,300,000 Current portion of long-term loans to other persons 1,765,000 1,680,000 company 5.4 30,000 - 30,000 - Inventories 7 7,629 - 7,099 - Costs of property development projects 8 194,435,521 182,440,750 55,836,094 61,816,292 100,203 102,589 21,838 23,027 Current tax assets 106 425 97 368 Other current financial assets 4, 10 1,027,601,000 757,619,998 1,027,601,000 757,619,998 Other current assets 4 45,936,951 49,147,951 15,140,676 17,302,331 9 1,878 - 1,878 - Total current assets 3,170,449,250 2,965,727,188 1,752,899,319 1,599,867,690 201,999 174,253 78,767 41,932 Non-current assets Fixed deposits pledged as collateral 9 39,927,925 50,575,874 - - Other non-current financial assets asset 4, 10 15,282,224,778 12,290,973,926 10,246,971,594 8,516,663,784 Investments in associates 11 3,199,195,914 2,996,605,672 1,703,494,168 1,703,494,168 Investments 46,939 - 46,939 - Bank deposits pledged as collateral 8,968 8,041 - - Investment in subsidiaries 12 10 - - 1,656,112,409 1,716,071,896 256,857 164,162 Other long-term investments 4, 11 - 46,939 - 46,939 Long-term loans to related parties 4 24,000,000 24,000,000 - - Long-term loans to other persons 38,716,857 29,771,857 Related companies 5.4 58,000 89,250 184,637 294,400 Other companies 12 3,875 4,602 - - Investment property 13 436,209,846 434,528,456 362,654,416 359,335,232 119,499 121,840 119,499 121,840 Property, plant and equipment 14 8,395,954,396 8,558,632,798 1,098,763,837 1,126,708,244 583,486 599,340 77,150 80,115 Right-of-use assets 15 26,551,026 264,051,602 13,428,879 16,206,273 Goodwill 723,215,731 723,215,731 51,027 - 602 - Intangible assets 13,264,824 15,153,918 663,298 772,023 16 33,816 34,480 12 16 Deferred tax assets 16 12,565,086 11,044,791 122 122 - - Advance payment for assets 4,135,794 51,615,987 - 47,204,850 Other non-current assets 12,868,530 10,770,664 2,151,123 2,766,616 825 831 13 13 Total non-current assets 28,208,830,707 25,460,941,276 15,084,239,724 13,489,223,086 TOTAL ASSETS 31,379,279,957 28,426,668,464 16,837,139,043 15,089,090,776 906,557 905,445 685,709 707,485 Total assets 1,108,556 1,079,698 764,476 749,417 Notes to the interim financial statements form an integral part of these interim financial statements. "UNAUDITED" "REVIEWED" - 4 - LIABILITIES AND SHAREHOLDERS' EQUITY Thousand Baht Consolidated financial statements Separate financial statements As at September June As at December As at September June As at December Notes Note 30, 2022 2020 31, 2021 2019 30, 2022 2020 31, 2021 2019 Current liabilities Bank overdarfts Trade and short-term loans from financial institutions other current payables Related companies 5.4, 17 4,506,347,747 3,821,506,379 3,280,000,000 2,740,000,000 Trade payables 4 419,141,232 398,333,646 116,142,678 112,223,155 - - 1,045 54 Other companies 17 8,312 7,905 5,267 3,931 Advance received from alternative vaccine Covid-19 400,678 324,141,324 - 293,670,056 Accrued doctor fee 237,341,253 216,828,881 98,899,051 93,823,407 Accrued expenses 4 124,574,869 168,529,241 29,969,025 105,411,652 Accrued dividends 27,699,857 24,580,167 17,267,271 15,222,804 Payable from acquisition of assets 4 119,349,128 154,436,309 1,188,718 4,842,073 under agreement to buy and to sell 3,348 1,961 1,543 575 Current portion of long-term borrowings 18 36,981 37,022 - - Current portion of lease liabilities Long-term loans from financial institution 20 1,340,080,006 1,345,080,005 713,525,720 719,525,720 Lease liabilities 21 7,632,819 22,591,526 4,457,371 6,315,949 4, 19 2,067 153 156 153 Short-term loans borrowings from related parties 4, 18 267,300,000 268,800,000 company 5.4 - - Short-term loans from other persons and other company 19 120,227,420 81,300,000 25,927,420 31,519 - Income tax payable 106,505,929 127,380,221 58,809,644 90,524,391 Advance received from social security office 26 350,944,553 370,144,553 - - Other current liabilities 4 88,240,687 50,729,673 16,490,595 47,214,973 Total current liabilities 7,715,786,178 7,374,381,925 4,362,677,493 4,228,774,180 50,708 47,041 39,530 4,713 Non-current liabilities Long-term loans borrowings from financial institutions 20 2,933,515,497 3,551,525,502 942,959,500 1,262,103,790 18 193,790 182,103 - - Lease liabilities 21 23,104,340 267,126,327 10,520,644 13,849,713 Long-term loans from related parties 4, 18 202,000,000 155,000,000 227,000,000 155,000,000 Deferred tax liabilities 16 1,995,679,464 1,482,606,553 1,011,850,925 735,715,039 Provisions 19 49,325 339 260 339 Non-current provisions for employee benefit 22 287,334,225 272,263,545 85,172,881 91,259,325 Other non-current liabilities 4 40,643,780 67,187,975 14,391,032 15,313,158 1,344 1,140 1,301 1,102 Total non-current liabilities 5,482,277,306 5,795,709,902 2,291,894,982 2,273,241,025 TOTAL LIABILITIES 13,198,063,484 13,170,091,827 6,654,572,475 6,502,015,205 244,459 183,582 1,561 1,441 Total liabilities 295,167 230,623 41,091 6,154 Notes to the interim financial statements form an integral part of these interim financial statements. "UNAUDITED" "REVIEWED" Thousand Baht Consolidated financial statements Separate financial statements As at September June As at December As at September June As at December Notes Note 30, 2022 2020 31, 2021 2019 30, 2022 2020 31, 2021 2019 Shareholders' ’ equity Share capital 23 Authorized share capital 16,019,683,830 818,024,729 ordinary shares, Baht 0.10 1.00 each 1,601,968,383 1,601,968,383 14,939,082,816 818,025 818,025 818,025 818,025 Issued and paid share capital 818,024,729 ordinary shares, Baht 0.10 1.00 each 1,493,908,282 1,493,908,282 Issued and paid-up share capital 13,576,011,474 818,025 818,025 818,025 818,025 Share premium on ordinary shares, Baht 0.10 each 1,357,601,147 1,357,601,147 13,575,865,582 ordinary shares, Baht 0.10 each 1,357,586,558 1,357,586,558 Premium on share capital 2,718,559,728 2,718,137,663 2,718,559,728 2,718,137,663 shares 624,226 624,226 624,226 624,226 Surpluses (deficits) from change in the ownership interest in subsidiary 66 (1,738) - - Retained earnings Appropriated Legal reserve 149,390,828 149,390,828 149,390,828 149,390,828 9,834 9,834 9,834 9,834 Unappropriated 4,271,811,378 3,729,084,936 1,706,269,862 1,355,614,395 Other components of shareholders' equity 10.1, 11.3 5,949,777,953 4,230,064,717 4,250,745,003 3,006,346,127 (697,855) (698,661) (728,700) (708,822) Total equity attributable to owners of the parent 14,447,141,034 12,184,264,702 10,182,566,568 8,587,075,571 754,296 751,686 723,385 743,263 Non-controlling interests 3,734,075,439 3,072,311,935 59,093 97,389 - - TOTAL SHAREHOLDERSTotal shareholders' EQUITY 18,181,216,473 15,256,576,637 10,182,566,568 8,587,075,571 TOTAL LIABIBITIE AND SHAREHOLDERSequity 813,389 849,075 723,385 743,263 Total liabilities and shareholders' EQUITY 31,379,279,957 28,426,668,464 16,837,139,043 15,089,090,776 equity 1,108,556 1,079,698 764,476 749,417 Notes to the interim financial statements form an integral part of these interim financial statements. "UNAUDITED" "REVIEWED" - 6 - FOR THE THREE-MONTH PERIOD ENDED SEPTEMBER 30, 2022 Baht Consolidated financial statements Separate financial statements Notes 2022 2021 2022 2021 Revenues 2020 2019 2020 2019 Revenues from medical treatment 4 2,155,163,346 1,895,010,776 814,506,560 844,090,017 Rental sales Revenues from rental and service income 4 18,081,940 15,832,052 18,830,484 16,299,479 services 5.3 Revenues from electricity current distribution Interest revenue 5.3 Gain (loss) on sale re-measurement fair value of investments in equity (43,471,819) 1,914,030 (43,471,819) 1,914,030 Dividend income 4, 10, 11, 12 87,813,447 50,311,033 67,104,150 39,367,683 Gain (loss) on sale of investments in subsidiary 12 (14,866,224) - 4,163,495 - financial assets Other income 4 27,554,391 19,153,239 14,397,821 10,454,296 Income Total revenues 2,230,275,081 1,982,221,130 875,530,691 912,125,505 Expenses Cost of medical treatment 4 1,422,953,034 1,248,129,753 432,248,549 510,148,581 sales Cost of rental and service 4 10,760,812 11,636,636 10,760,811 8,794,829 Cost of electricity current distribution Cost of distribution Administrative and services expenses 4 264,504,868 232,499,406 98,125,978 98,465,395 Loss on fair value measurement of financial assets 34,670,975 87,599,842 34,670,975 87,599,842 5.3 Total expenses 1,732,889,689 1,579,865,637 575,806,313 705,008,647 Profit (loss) from operating activities 497,385,392 402,355,493 299,724,378 207,116,858 Finance costs 4 61,601,273 52,670,324 31,932,254 30,472,313 Share of profit of associates 11.2 62,937,196 407,626,526 - - 5.3 Profit (loss) before income tax expenses 498,721,315 757,311,695 267,792,124 176,644,545 Income tax expenses 27 98,091,208 50,517,131 58,511,423 27,517,628 Profit (loss) for the period from continuing operations 400,630,107 706,794,564 209,280,701 149,126,917 Discontinued operation Loss for the period from discontinued operations 28 (12,953,267) (19,580,348) - - Profit for the period 387,676,840 687,214,216 209,280,701 149,126,917 Other comprehensive income Item that will not be reclassified subsequently to profit or loss Gain Gains on investments in equity designated at fair value through other comprehensive income 1,135,099,331 973,267,888 810,731,642 772,133,964 Share re-measurements of other comprehensive gain of associates 11.3 (17,731,778) (3,205,147) - - Income tax relating to items that will not be reclassified subsequently to profit or loss 27 (207,996,606) (193,920,411) (143,271,208) (153,693,625) defined benefit plans Other comprehensive income (loss) for the period, net of income tax 909,370,947 776,142,330 667,460,434 618,440,339 period Total comprehensive income (expenses) for the period 1,297,047,787 1,463,356,546 876,741,135 767,567,256 - (118) Notes to the interim financial statements form an integral part of these interim financial statements. "UNAUDITED" "REVIEWED" from continuing operations from discontinued operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations Baht Consolidated financial statements Separate financial statements 2022 2021 2022 2021 2020 2019 2020 2019 Note - (19,580,348) 387,676,840 687,214,216 209,280,701 149,126,917 1,297,047,787 1,463,356,546 876,741,135 767,567,256 Earnings per share 30 Basic earnings per share Attributable to owners of the parent from continuing operations 0.0243 0.0494 0.0154 0.0110 from discontinued operations (0.0010) (0.0015) - - Attributable to owners of the parent from continuing operations from discontinued operations 0.0243 0.0450 0.0154 0.0100 (0.0010) (0.0013) - - 0.0233 0.0437 0.0154 0.0100 0.0233 0.0479 0.0154 0.0110 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" - 8 - FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2022 Baht Consolidated financial statements Separate financial statements Notes 2022 2021 2022 2021 Revenues Revenues from medical treatment 4 6,666,763,946 4,951,934,066 2,454,948,755 2,016,859,325 Rental and service income 4 53,671,650 44,906,451 58,478,821 47,784,859 Gain (loss) on sale of investments in equity (20,858,407) 20,900,205 (20,858,407) 20,900,205 Dividend income 4, 10, 11, 12 273,071,811 166,002,212 595,102,924 295,083,854 Gain (loss) on sale of investments in subsidiary 12 (14,866,224) - 4,163,495 - Other income 4 81,651,974 65,329,683 35,808,046 34,419,361 Total revenues 7,039,434,750 5,249,072,617 3,127,643,634 2,415,047,604 Expenses Cost of medical treatment 4 4,391,862,627 3,498,789,024 1,492,819,355 1,314,170,861 Cost of rental and service 4 27,881,107 29,103,123 30,263,832 26,505,673 Administrative and services expenses 4 792,392,567 684,596,693 296,988,809 287,323,659 (Gain) loss on fair value measurement of financial assets 182,897,083 (19,337,808) 182,897,083 (19,337,808) Total expenses 5,395,033,384 4,193,151,032 2,002,969,079 1,608,662,385 Profit from operating activities 1,644,401,366 1,055,921,585 1,124,674,555 806,385,219 Finance costs 4 180,094,610 146,171,279 92,906,307 88,734,845 Share of profit of associates 11.2 164,768,713 463,571,203 - - Profit before income tax expenses 1,629,075,469 1,373,321,509 1,031,768,248 717,650,374 Income tax expenses 27 255,227,401 140,891,055 104,414,869 83,146,186 Profit for the period from continuing operations 1,373,848,068 1,232,430,454 927,353,379 634,504,188 Discontinued operation Loss for the period from discontinued operations 28 (35,889,623) (27,040,624) - - Profit for the period 1,337,958,445 1,205,389,830 927,353,379 634,504,188 Other comprehensive income Item that will not be reclassified subsequently to profit or loss Gain on investments in equity designated at fair value through other comprehensive income 2,900,894,957 1,905,830,248 1,649,873,603 1,744,258,730 Actuarial gain on defined employee benefit plans 22 9,650,094 - 9,650,094 - Share of other comprehensive gain of associates 11.3 4,804,650 43,055,876 - - Income tax relating to items that will not be reclassified subsequently to profit or loss 27 (562,590,885) (380,432,883) (313,029,619) (348,118,578) Other comprehensive income for the period, net of income tax 2,352,758,816 1,568,453,241 1,346,494,078 1,396,140,152 Total comprehensive income for the period 3,690,717,261 2,773,843,071 2,273,847,457 2,030,644,340 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" Baht Separate financial statements from continuing operations from discontinued operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations Owners of the parent from continuing operations from discontinued operations Non-controlling interests from continuing operations 2022 2021 2022 2021 3,726,606,884 2,800,883,695 2,273,847,457 2,030,644,340 1,337,958,445 1,205,389,830 927,353,379 634,504,188 3,690,717,261 2,773,843,071 2,273,847,457 2,030,644,340 Earnings per share 30 Basic earnings per share Attributable to owners of the parent from continuing operations 0.0843 0.0840 0.0683 0.0467 from discontinued operations (0.0026) (0.0019) - - Attributable to owners of the parent from continuing operations from discontinued operations 0.0843 0.0766 0.0683 0.0426 (0.0026) (0.0018) - - 0.0817 0.0748 0.0683 0.0426 0.0817 0.0821 0.0683 0.0467 Notes to the interim financial statements form an integral part of these statements. "UNAUDITED" "REVIEWED" FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2022 Baht Consolidated financial statements Equity attributable to owners of the parent Non-controlling Total Issued and Share premium Retained earnings Other components of shareholders' equity Total equity interests Shareholders' paid-up share account Appropriated Unappropriated Unrealized gain Unrealized gain Unrealized loss Difference from Total other attributable to equity capital Legal reserve (loss) on (loss) on on investment change in shareholding components owners of investments investment in associates proportion in subsidiary shareholders' the parent in equity in associates equity 1,357,586,558 2,718,137,663 149,390,828 3,729,084,936 3,983,057,900 232,007,542 (592,389) 15,591,664 4,230,064,717 12,184,264,702 3,072,311,935 15,256,576,637 Notes Balance as at January 1, 2022 Paid-up share capital 24 Dividend paid 25 Non-contralling interest increase from acquisition of investment in subsidiaries - - - - - - - - - - 2,000,000 2,000,000 Total comprehensive income for the period Profit for the period - - - 1,108,728,625 - - - - - 1,108,728,625 229,229,820 1,337,958,445 Other comprehensive income for the period, net of income tax Gain on valuation of investments - - - - 1,810,433,012 - - - 1,810,433,012 1,810,433,012 529,801,079 2,340,234,091 Gain on derecognition of investment in equity designated at fair value through other comprehersive income - 95,524,426 Actuarial gain on defined employee benefit plans - 7,720,075 - - Share of other comprehensive gain of associates - - 4,804,650 - Balance as at September 30, 2022 2,718,559,728 4,271,811,378 236,812,192 15,591,664 149,390,828 3,734,075,439 Notes to the interim financial statements form an integral part of these financial statements. "UNAUDITED" "REVIEWED" FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2022118)